| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | President And CEO | See Remarks
1 company
Lanfear Dennis M is a President &CEO at Coherus Oncology, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | CHRS Coherus Oncology, Inc. | President &CEO | Sale+OE | 223,100 | $2.02 | $449,769.60 | -23.4% | +28.2% | -45.5% | |
| Jun 8, 2021 | CHRS Coherus Oncology, Inc. | President &CEO | Sale+OE | 31,054 | $13.56 | $421,228.88 | -5.9% | +11.3% | -43.0% | |
| Nov 21, 2019 | CHRS Coherus Oncology, Inc. | President &CEO | Sell | 12,500 | $18.56 | $231,960.00 | -2.7% | - | - | |
| Nov 20, 2019 | CHRS Coherus Oncology, Inc. | President &CEO | Sell | 825,000 | $18.00 | $14,850,000.00 | -64.2% | - | - | |
| May 30, 2019 | CHRS Coherus Oncology, Inc. | President &CEO | Sell | 32,398 | $19.49 | $631,281.51 | -2.5% | - | - | |
| May 16, 2018 | CHRS Coherus Oncology, Inc. | See Remarks | Sell | 20,984 | $16.26 | $341,264.89 | -1.6% | - | - | |
| Sep 21, 2016 | CHRS Coherus Oncology, Inc. | President And CEO | Sell | 4,060 | $31.75 | $128,909.81 | -0.2% | - | - | |
| Sep 16, 2016 | CHRS Coherus Oncology, Inc. | President And CEO | Sell | 2,900 | $31.79 | $92,199.12 | -0.2% | - | - | |
| Nov 30, 2015 | CHRS Coherus Oncology, Inc. | President And CEO | Sell | 400 | $31.75 | $12,700.00 | - | - | - |